Dr. Sourjya P. Misra, MD

Dr. Misra practices at Chabot Urology Medcal Associates, a Professional Corp. in Castro Valley, California.

Dr. Misra's NPI, 1699706366, was assigned on July 5, 2006. Dr. Misra graduated from SCB Medical College Cuttak in 1977. Dr. Misra holds California license A49141.

Dr. Misra's primary practice is Chabot Urology Medcal Associates, a Professional Corp., at 20055 Lake Chabot Rd, Castro Valley, CA 94546 in Alameda County. The practice phone is (510) 889-9166.

Dr. Misra's primary practice is Chabot Urology Medcal Associates, a Professional Corp. in Castro Valley, California. Dr. Misra is also affiliated with Sutter Eden Medical Center. Dmand AI also links Dr. Misra to 2 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Misra practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Misra's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Misra is board certified in urology by the American Board of Urology. Dmand AI has Dr. Misra's licenses on file in 5 states: California, New Jersey, New York, Pennsylvania and Illinois.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Misra treats.

CMS data shows 1,623 Medicare services from Dr. Misra across 10 procedure codes in 2024, for 356 Medicare patients. Medicare paid $135,833 for them.

CMS counts 356 Medicare patients who saw Dr. Misra in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Misra's median patient age at 72, with 19% women.

In 2024, Dr. Misra wrote 1,673 Medicare Part D claims for 386 patients. 94% of them were for generic drugs. CMS names the drug for 1,565 of them, across 17 drugs with 11 or more claims each, at $108,121 in total drug cost. In 2023, CMS named 1,651 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Misra for performance year 2024, reported individually. Dr. Misra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Misra as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Misra, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 77 general payments to Dr. Misra from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Astellas Pharma US Inc paid the most, $785.

Dmand AI lists 2 awards for Dr. Misra, most recently CMS Stage 1 2012 in 2012.

Dr. Misra graduated from SCB Medical College Cuttak in 1977. Dr. Misra is a member of ACS.

Dr. Misra is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.